Archive

Compounded GLP-1 Drugs Remain Prevalent After Drug Shortage

Patients may still use unregulated compounded GLP-1s; verify sources and counsel on safety now that branded options are available.

Endocrinology · JAMA · 1 Sept

Solera Health adds Noom to weight management offerings

Expands patient access to structured weight-loss programs and GLP-1 support, potentially improving adherence and outcomes in obesity care.

Endocrinology · Fierce Healthcare · 31 Aug

Why Roche is 'really excited' about a UCN2 analog for obesity after seeing preclinical data

A UCN2 analog may preserve lean muscle during weight loss—unlike GLP-1s—so watch for trials if you manage obesity.

Endocrinology · Fierce Biotech · 28 Aug

FDA Authorizes First Wearable Device That Continuously Monitors Both Ketone Levels and Blood Sugar

For your diabetic patients, this single wearable replaces separate glucose and ketone sensors, enabling earlier detection of ketoacidosis risk.

Endocrinology · FDA — Press Announcements · 25 Aug